Iron sucrose
Clinical data | |
---|---|
Trade names | Venofer |
AHFS/Drugs.com | FDA Professional Drug Information |
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | B03AC (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
Chemical and physical data | |
Formula | [Na2Fe5O8(OH) •3(H2O)]n •m(C12H22O11) |
Molar mass | 34,000 to 60,000 g/mol |
Iron sucrose (brand name Venofer) is an intravenously administered iron product indicated in the treatment of iron deficiency anemia.[1] It is frequently used in patients undergoing hemodialysis, those undergoing erythropoietin therapy, and/or patients who have chronic kidney disease. It is a type 2 complex which limits the maximum dose that can be given to 1000mg which requires 5-10 administrations.
References
- ↑ "Iron Sucrose (Intravenous Route)". Mayo Clinic. Retrieved 22 January 2016.
External links
- Venofer venofer on Drugs.com
- Venofer brand website
This article is issued from Wikipedia - version of the 6/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.